ANI Pharmaceuticals, Inc. (ANIP)

NASDAQ: ANIP · Real-Time Price · USD

75.76

-2.49 (-3.18%)

At close: Aug 10, 2026, 4:00 PM EDT

76.76

+1.00 (1.32%)

After-hours: Aug 10, 2026, 7:46 PM EDT

ANI Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	978.38	883.37	614.38	486.82	316.39	216.14
Revenue Growth	30.90%	43.78%	26.20%	53.87%	46.38%	3.67%
Cost of Revenue	387.4	341.31	250.21	181.51	138.79	100.61
Gross Profit	590.98	542.06	364.17	305.3	177.6	115.53
Selling, General & Admin	324.76	317.75	249.64	161.7	124.04	84.29
Depreciation & Amortization Expenses	85.8	91.42	67.73	59.79	56.97	47.25
Research & Development	49.91	51.66	44.58	34.29	22.32	11.37
Other Operating Expenses	-19.85	-29.86	12.33	2.56	9.55	12.4
Total Operating Expenses	440.63	430.96	374.28	258.33	212.88	155.32
Operating Income	150.36	111.09	0.58	46.97	-35.28	-39.79
Interest Expense	-16.54	-20.06	-17.6	-26.94	-28.05	-11.92
Other Non-Operating Income (Expense)	8.79	4.76	-16.85	-0.16	0.67	-4.34
Total Non-Operating Income (Expense)	-7.76	-15.3	-34.45	-27.1	-27.38	-16.27
Pretax Income	142.6	95.79	-22.21	19.87	-62.67	-56.06
Provision for Income Taxes	34.29	17.45	-3.69	1.09	-14.77	-13.46
Net Income	108.31	78.34	-18.52	18.78	-47.9	-42.6
Net Income Attributable to Preferred Dividends	-	1.16	-	-	-	-
Net Income to Common	108.31	77.18	-18.52	18.78	-47.9	-42.6
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	21	20	19	18	16	13
Shares Outstanding (Diluted)	21	21	19	18	16	13
Shares Change	7.71%	9.89%	6.18%	11.89%	29.77%	4.73%
EPS (Basic)	4.83	3.50	-1.04	0.86	-3.05	-3.40
EPS (Diluted)	4.64	3.32	-1.04	0.85	-3.05	-3.40
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-	0	47.78	110.09	-40.08	0.77
Free Cash Flow Growth	-	-	-56.60%	-	-	-91.62%
Free Cash Flow Per Share	-	-	2.47	6.05	-2.46	0.06
Gross Margin	60.40%	61.36%	59.27%	62.71%	56.13%	53.45%
Operating Margin	15.37%	12.58%	0.10%	9.65%	-11.15%	-18.41%
Profit Margin	11.07%	8.87%	-3.01%	3.86%	-15.14%	-19.71%
FCF Margin	-	0.00%	7.78%	22.61%	-12.67%	0.35%
EBITDA	150.36	111.09	68.32	106.76	24.37	7.46
EBITDA Margin	15.37%	12.58%	11.12%	21.93%	7.70%	3.45%
EBIT	150.36	111.09	0.58	46.97	-35.28	-39.79
EBIT Margin	15.37%	12.58%	0.10%	9.65%	-11.15%	-18.41%
Effective Tax Rate	24.04%	18.22%	16.61%	5.50%	23.57%	24.00%

SEC Filings: 10-K · 10-Q